Furthermore, RIPK1 kinase activation in microglia and astrocytes in vitro drives an inflammatory transcriptional response with harmful non-cell-autonomous consequences to oligodendrocytes and translational relevance to MS pathology. Here, RIPK1 is linked to myeloid sarcoma.